The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO).

XI'AN, China, Nov. 15, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is taking part in the Fourth International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO) sponsored by the China Anti-Cancer Association (CACA), Chinese Institute of Development Strategy on Holistic Integrative Medicine, and Asian Oncology Society (AOS). The three-day event highlights international collaborations to improve cancer treatment and outcomes across China and beyond.

"NCCN is honored to participate in this important meeting," said Wui-Jin Koh, MD, Chief Medical Officer, NCCN. "China is one of the top three countries in the world in terms of number of registered users for our website and downloads of NCCN Guidelines. We are grateful that our evidence-based expert consensus-driven recommendations are being utilized to guide and improve care for people with cancer throughout China and all of Asia."

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) help define and advance high-quality, high-value, patient-centered cancer care globally. There are 88 different NCCN Guidelines®, featuring recommendations from multi-disciplinary expert panels for treating nearly the vast majority of cancer types, plus screening, prevention, and supportive care. They are the most thorough and frequently updated clinical practice guidelines available in any area of medicine. NCCN Guidelines were downloaded more than 15 million times in 2023 worldwide, with nearly a million downloads from China alone.

NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives. NCCN is pleased to collaborate with leading oncology groups in China, including:

Chinese Gynecologic Cancer Society (CGCS) and Shanghai Yanxin Cultural Firm
Through this ongoing collaboration, NCCN works with leading gynecologic experts in China to translate, adapt, and update NCCN Guidelines for Gynecologic Cancers, including Cervical Cancer, Gestational Trophoblastic Neoplasia, Ovarian Cancer, Uterine Neoplasms, and Vulvar Cancer.
Medlive
This recently-renewed collaboration facilitates the dissemination of NCCN Guidelines in English and Chinese via nccnchina.org.cn, and Medlive's platforms for computer, smartphone, and tablet.

NCCN's resources are available for free to people everywhere, including more than 100,000 registered users in China. NCCN Guidelines have been translated more than 250 times across approximately 50 languages, including 30 NCCN Guidelines in Chinese. The NCCN Global Program also provides free access to International Adaptations, NCCN Framework for Resource Stratification (NCCN Framework™), and NCCN Harmonized Guidelines™, which feature pragmatic approaches for defining appropriate treatment tailored to unique regional circumstances. Learn more and access all of these materials by visiting NCCN.org/global. 

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

PR Newswire Asia Ltd.

PR Newswire
1954年に設立された世界初の米国広報通信社です。配信ネットワークで全世界をカバーしています。Cision Ltd.の子会社として、Cisionクラウドベースコミュニケーション製品、世界最大のマルチチャネル、多文化コンテンツ普及ネットワークと包括的なワークフローツールおよびプラットフォームを組み合わせることで、様々な組織のストーリーを支えています。www.prnasia.com